Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 659282, 6 pages
http://dx.doi.org/10.1155/2013/659282
Review Article

Role of Matrix Metalloproteinase-8 in Atherosclerosis

1Cardiology Division, Department of Medicine, Geneva University Hospital, Foundation for Medical Research, 1211 Geneva 4, Switzerland
2Clinic of Internal Medicine 1, Department of Internal Medicine, University of Genoa, 16100 Genoa, Italy

Received 22 September 2012; Accepted 20 December 2012

Academic Editor: Jane Stubbe

Copyright © 2013 Sébastien Lenglet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Baker, D. R. Edwards, and G. Murphy, “Metalloproteinase inhibitors: biological actions and therapeutic opportunities,” Journal of Cell Science, vol. 115, no. 19, pp. 3719–3727, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Lutgens, S. P. M. Lutgens, B. C. G. Faber et al., “Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation,” Circulation, vol. 113, no. 1, pp. 98–107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. F. Mahmood, I. Jguirim-Souissi, El.-H. Khadija et al., “Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis,” Journal of Biological Chemistry, vol. 286, no. 33, pp. 28858–28866, 2011. View at Google Scholar
  4. Z. S. Galis, G. K. Sukhova, M. W. Lark, and P. Libby, “Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques,” Journal of Clinical Investigation, vol. 94, no. 6, pp. 2493–2503, 1994. View at Google Scholar · View at Scopus
  5. G. K. Sukhova, U. Schönbeck, E. Rabkin et al., “Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques,” Circulation, vol. 99, no. 19, pp. 2503–2509, 1999. View at Google Scholar · View at Scopus
  6. M. J. Hobeika, R. W. Thompson, B. E. Muhs, P. C. Brooks, and P. J. Gagne, “Matrix metalloproteinases in peripheral vascular disease,” Journal of Vascular Surgery, vol. 45, no. 4, pp. 849–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. L. Brown, M. S. Hibbs, M. Kearney, and J. M. Isner, “Differential expression of 92-kDa gelatinase in primary atherosclerotic versus restenotic coronary lesions,” American Journal of Cardiology, vol. 79, no. 7, pp. 878–882, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Montecucco, V. Di Marzo, R. F. da Silva et al., “The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques,” European Heart Journal, vol. 33, no. 7, pp. 846–856, 2012. View at Publisher · View at Google Scholar
  9. D. L. Brown, M. S. Hibbs, M. Kearney, C. Loushin, and J. M. Isner, “Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina,” Circulation, vol. 91, no. 8, pp. 2125–2131, 1995. View at Google Scholar · View at Scopus
  10. C. B. Jones, D. C. Sane, and D. M. Herrington, “Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome,” Cardiovascular Research, vol. 59, no. 4, pp. 812–823, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Murphy, J. J. Reynolds, U. Bretz, and M. Baggiolini, “Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analyses of their actions on soluble and insoluble collagens,” Biochemical Journal, vol. 203, no. 1, pp. 209–221, 1982. View at Google Scholar · View at Scopus
  12. K. A. Hasty, J. J. Jeffrey, M. S. Hibbs, and H. G. Welgus, “The collagen substrate specificity of human neutrophil collagenase,” Journal of Biological Chemistry, vol. 262, no. 21, pp. 10048–10052, 1987. View at Google Scholar · View at Scopus
  13. V. Knäuper, G. Murphy, and H. Tschesche, “Activation of human neutrophil procollagenase by stromelysin 2,” European Journal of Biochemistry, vol. 235, no. 1-2, pp. 187–191, 1996. View at Google Scholar · View at Scopus
  14. K. A. Hasty, T. F. Pourmotabbed, G. I. Goldberg et al., “Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases,” Journal of Biological Chemistry, vol. 265, no. 20, pp. 11421–11424, 1990. View at Google Scholar · View at Scopus
  15. M. P. Herman, G. K. Sukhova, P. Libby et al., “Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling,” Circulation, vol. 104, no. 16, pp. 1899–1904, 2001. View at Google Scholar · View at Scopus
  16. C. M. Dollery, C. A. Owen, G. K. Sukhova, A. Krettek, S. D. Shapiro, and P. Libby, “Neutrophil elastase in human atherosclerotic plaques production by macrophages,” Circulation, vol. 107, no. 22, pp. 2829–2836, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Okada and I. Nakanishi, “Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G,” FEBS Letters, vol. 249, no. 2, pp. 353–356, 1989. View at Google Scholar · View at Scopus
  18. Y. Itoh and H. Nagase, “Preferential inactivation of tissue inhibitor of metalloproteinase-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase,” Journal of Biological Chemistry, vol. 270, no. 28, pp. 16518–16521, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Ferry, M. Lonchampt, L. Pennel, G. De Nanteuil, E. Canet, and G. C. Tucker, “Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury,” FEBS Letters, vol. 402, no. 2-3, pp. 111–115, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Paulsson, E. Dadfar, C. Held, S. H. Jacobson, and J. Lundahl, “Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease,” Atherosclerosis, vol. 192, no. 2, pp. 328–334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Naruko, M. Ueda, K. Haze et al., “Neutrophil infiltration of culprit lesions in acute coronary syndromes,” Circulation, vol. 106, no. 23, pp. 2894–2900, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Dorweiler, M. Torzewski, M. Dahm, C. J. Kirkpatrick, K. J. Lackner, and C. F. Vahl, “Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima,” Thrombosis and Haemostasis, vol. 99, no. 2, pp. 373–381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. K. J. Molloy, M. M. Thompson, J. L. Jones et al., “Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity,” Circulation, vol. 110, no. 3, pp. 337–343, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. T. Nikkari, K. D. O'Brien, M. Ferguson et al., “Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis,” Circulation, vol. 92, no. 6, pp. 1393–1398, 1995. View at Google Scholar · View at Scopus
  25. G. K. Sukhova, U. Schönbeck, E. Rabkin et al., “Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques,” Circulation, vol. 99, no. 19, pp. 2503–2509, 1999. View at Google Scholar · View at Scopus
  26. J. P. G. Sluijter, W. P. C. Pulskens, A. H. Schoneveld et al., “Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms,” Stroke, vol. 37, no. 1, pp. 235–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Peeters, F. L. Moll, A. Vink et al., “Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome,” European Heart Journal, vol. 32, no. 18, pp. 2314–2325, 2011. View at Publisher · View at Google Scholar
  28. R. C. Laxton, Y. Hu, J. Duchene et al., “A role of matrix metalloproteinase-8 in atherosclerosis,” Circulation Research, vol. 105, no. 9, pp. 921–929, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Van Lint and C. Libert, “Matrix metalloproteinase-8: cleavage can be decisive,” Cytokine and Growth Factor Reviews, vol. 17, no. 4, pp. 217–223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. P. E. Tummala, X. L. Chen, C. L. Sundell et al., “Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis,” Circulation, vol. 100, no. 11, pp. 1223–1229, 1999. View at Google Scholar · View at Scopus
  31. M. E. Pueyo, W. Gonzalez, A. Nicoletti, F. Savoie, J. F. Arnal, and J. B. Michel, “Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 3, pp. 645–651, 2000. View at Google Scholar · View at Scopus
  32. M. Naghavi, P. Libby, E. Falk et al., “From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies—part I,” Circulation, vol. 108, no. 14, pp. 1664–1672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Naghavi, P. Libby, E. Falk et al., “From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies—part II,” Circulation, vol. 108, no. 15, pp. 1772–1778, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Danesh, J. G. Wheeler, G. M. Hirschfield et al., “C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease,” The New England Journal of Medicine, vol. 350, no. 14, pp. 1387–1397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Inokubo, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, and K. Okumura, “Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome,” American Heart Journal, vol. 141, no. 2, pp. 211–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. M. H. Tayebjee, G. Y. H. Lip, K. T. Tan, J. V. Patel, E. A. Hughes, and R. J. MacFadyen, “Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease,” American Journal of Cardiology, vol. 96, no. 3, pp. 339–345, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Taurino, S. Raffa, M. Mastroddi et al., “Metalloproteinase expression in carotid plaque and its correlation with plasma levels before and after carotid endarterectomy,” Vascular and Endovascular Surgery, vol. 41, no. 6, pp. 516–521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Zucker, M. Hymowitz, C. Conner et al., “Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications,” Annals of the New York Academy of Sciences, vol. 878, pp. 212–227, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. M. M. Turu, J. Krupinski, E. Catena et al., “Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound,” Atherosclerosis, vol. 187, no. 1, pp. 161–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Kato, Y. Momiyama, R. Ohmori, H. Taniguchi, H. Nakamura, and F. Ohsuzu, “Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease,” Circulation Journal, vol. 69, no. 9, pp. 1035–1040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Momiyama, R. Ohmori, N. Tanaka et al., “High plasma levels of matrix metalloproteinase-8 in patients with unstable angina,” Atherosclerosis, vol. 209, no. 1, pp. 206–210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. P. J. Pussinen, S. Sarna, M. Puolakkainen, H. Ohlin, T. Sorsa, and E. Pesonen, “The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence,” International Journal of Cardiology. In press. View at Publisher · View at Google Scholar
  43. H. Alfakry, J. Sinisalo, S. Paju et al., “The association of serum neutrophil markers and acute coronary syndrome,” Scandinavian Journal of Immunology, vol. 76, no. 2, pp. 181–187, 2012. View at Publisher · View at Google Scholar
  44. A. M. Tuomainen, K. Nyyssönen, J. A. Laukkanen et al., “Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2722–2728, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. G. D. Smith and S. Ebrahim, “'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?” International Journal of Epidemiology, vol. 32, no. 1, pp. 1–22, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Zhang, S. Ye, S. M. Herrmann et al., “Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis,” Circulation, vol. 99, no. 14, pp. 1788–1794, 1999. View at Google Scholar · View at Scopus
  47. E. Pearce, D. A. Tregouet, A. Samnegård et al., “Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction,” Circulation Research, vol. 97, no. 10, pp. 1070–1076, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Abilleira, S. Bevan, and H. S. Markus, “The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis,” Journal of Medical Genetics, vol. 43, no. 12, pp. 897–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Devarajan, K. Mookhtiar, H. Van Wart, and N. Berliner, “Structure and expression of the cDNA encoding human neutrophil collagenase,” Blood, vol. 77, no. 12, pp. 2731–2738, 1991. View at Google Scholar · View at Scopus
  50. A. M. Pendás, I. Santamaría, M. V. Alvarez et al., “Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22. 3,” Genomics, vol. 37, no. 2, pp. 266–268, 1996. View at Publisher · View at Google Scholar
  51. T. Djurić, A. Stanković, I. Končar et al., “Association of MMP-8 promoter gene polymorphisms with carotid atherosclerosis: preliminary study,” Atherosclerosis, vol. 219, no. 2, pp. 673–678, 2011. View at Publisher · View at Google Scholar
  52. H. Wang, S. Parry, G. Macones et al., “Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM),” Human Molecular Genetics, vol. 13, no. 21, pp. 2659–2669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Lee, H. R. Kim, J. W. Min et al., “Lack of association between matrix metalloproteinase 8 promoter polymorphism and bronchiectasis in Koreans,” Journal of Korean Medical Science, vol. 22, no. 4, pp. 667–671, 2007. View at Google Scholar · View at Scopus
  54. W. Qiu, G. Zhou, Y. Zhai et al., “No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 9, pp. 2514–2518, 2008. View at Publisher · View at Google Scholar · View at Scopus